Mortgage Rates Hit 7.3%; PCE Data & Iran Talks Move Markets

This week’s healthcare candidate pool skews heavily toward pharma licensing, digital health fundraising, and large nonprofit hospital mergers — none of which qualify as small-to-medium practice acquisitions. The one deal approaching that territory is the HealthPartners–Essentia Health merger, but at a combined $12.5 billion enterprise spanning 22 hospitals and 1.6 million insurance members, it exceeds the scope of this section. No specific small or medium independent practice, clinic, DSO, or MSO acquisition was reported in the available sources this week.

What is moving the broader market: Health-tech M&A activity is described as accelerating in 2026, driven by AI capability and scale ambitions. Meanwhile, Tiny Health closed a $33 million Series B led by B Capital to expand microbiome testing services — a notable growth-stage raise for a diagnostics startup. On the pharma side, Merck paid $400 million for global rights to a KRAS G12D cancer drug candidate from China-based SciBrunch Therapeutics, and Novo Nordisk agreed to pay Hengrui up to $2.6 billion for a once-weekly oral obesity pill. These are large biopharma transactions, not practice-level deals, but they signal continued aggressive dealmaking across healthcare sub-sectors.

Markets enter the final stretch of September with several high-stakes catalysts in focus. Investors are watching closely for the Federal Reserve’s preferred inflation gauge — the PCE price index — which could influence near-term interest rate expectations. Strategists at Manulife note that bonds remain broadly disliked and see PCE data as a potential turning point for fixed-income sentiment.

Mortgage rates hit a near three-year high. US mortgage rates climbed for a sixth consecutive week, reaching 7.3% — the highest level in nearly three years. Higher borrowing costs continue to squeeze would-be homebuyers and weigh on housing activity. This trend reinforces how elevated rates are still feeding through to the real economy even as market participants debate the Fed’s next move.

Oil stays near $100 as Hormuz flows recover. Crude oil continues to trade around $100 a barrel. JPMorgan and Goldman Sachs both estimate that oil flows through the Strait of Hormuz are approaching pre-war levels, adding supply to a tight market. However, Iraq deepened its October price discounts by as much as $37 a barrel to benchmark, signaling competitive pressure among OPEC producers. Separately, the White House is weighing a potential US diesel export ban — a move Bank of America analysts say carries significant implications for domestic fuel prices and global supply chains.

US-Iran talks stall, raising military risk. Diplomatic efforts brokered by Qatar made little progress this week. According to sources familiar with the talks, neither Washington nor Tehran budged on core demands. US officials believe renewed military operations could follow the midterm elections. The stalemate is already lifting energy market risk premiums, with UK household energy bills forecast to rise to nearly £2,000 as Iran-related supply concerns push up gas prices.

AI valuations keep climbing. A leaked IPO prospectus from Anthropic reportedly outlined a path to a valuation above $2 trillion — while also warning investors of potential “catastrophic or existential risks.” Meanwhile, OpenAI is said to be seeking at least $30 billion in private funding at a roughly $1.4 trillion valuation, even as it delays a public offering. Trump hosted an AI-focused White House event with Nvidia CEO Jensen Huang, signaling continued federal interest in AI policy. Trending commentary this week reflects growing anxiety about stretched AI valuations and concentration risk in tech.

Renewables face a post-2028 cliff. Wind and solar additions are on pace for a record first half of 2026. However, the American Clean Power Association warns that growth could fall sharply by 2028 or 2029 if permitting blockades continue. The Republican tax law signed in July 2025 accelerated the expiration of federal clean-energy tax credits. Senate negotiators are working toward a bipartisan permitting deal, though a final vote is not expected before the midterms.